On-column ligand exchange for structure-based drug design: a case study with human 11β-hydroxysteroid dehydrogenase type 1

Acta Crystallogr Sect F Struct Biol Cryst Commun. 2012 May 1;68(Pt 5):601-5. doi: 10.1107/S1744309112010172. Epub 2012 Apr 21.

Abstract

Successfully forming ligand-protein complexes with specific compounds can be a significant challenge in supporting structure-based drug design for a given protein target. In this respect, an on-column ligand- and detergent-exchange method was developed to obtain ligand-protein complexes of an adamantane series of compounds with 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) after a variety of other complexation methods had failed. This report describes the on-column exchange method and an unexpected byproduct of the method in which artificial trimers were observed in the structures.

MeSH terms

  • 11-beta-Hydroxysteroid Dehydrogenase Type 1 / antagonists & inhibitors
  • 11-beta-Hydroxysteroid Dehydrogenase Type 1 / chemistry
  • Crystallography, X-Ray / instrumentation
  • Crystallography, X-Ray / methods*
  • Drug Design*
  • Enzyme Inhibitors / chemistry*
  • Humans
  • Ligands
  • Models, Molecular
  • Protein Structure, Quaternary

Substances

  • Enzyme Inhibitors
  • Ligands
  • 11-beta-Hydroxysteroid Dehydrogenase Type 1
  • HSD11B1 protein, human